| Oral rivaroxaban for the treatment of symptomatic pulmonary embolism Einstein–PE Investigators New England journal of medicine 366 (14), 1287-1297, 2012 | 2721 | 2012 |
| Oral apixaban for the treatment of acute venous thromboembolism G Agnelli, HR Buller, A Cohen, M Curto, AS Gallus, M Johnson, ... New England Journal of Medicine 369 (9), 799-808, 2013 | 2606 | 2013 |
| Venous thromboembolism (VTE) in Europe AT Cohen, G Agnelli, FA Anderson, JI Arcelus, D Bergqvist, JG Brecht, ... Thrombosis and haemostasis 98 (10), 756-764, 2007 | 2193 | 2007 |
| A comparison of enoxaparin with placebo for the prevention of venous thromboembolism in acutely ill medical patients MM Samama, AT Cohen, JY Darmon, L Desjardins, A Eldor, C Janbon, ... New England Journal of Medicine 341 (11), 793-800, 1999 | 2085 | 1999 |
| Venous thromboembolism risk and prophylaxis in the acute hospital care setting (ENDORSE study): a multinational cross-sectional study AT Cohen, VF Tapson, JF Bergmann, SZ Goldhaber, AK Kakkar, ... The lancet 371 (9610), 387-394, 2008 | 1857 | 2008 |
| Apixaban for extended treatment of venous thromboembolism G Agnelli, HR Buller, A Cohen, M Curto, AS Gallus, M Johnson, A Porcari, ... New England Journal of Medicine 368 (8), 699-708, 2013 | 1582 | 2013 |
| Duration of prophylaxis against venous thromboembolism with enoxaparin after surgery for cancer D Bergqvist, G Agnelli, AT Cohen, A Eldor, PE Nilsson, ... New England Journal of Medicine 346 (13), 975-980, 2002 | 1359 | 2002 |
| Randomized, placebo-controlled trial of dalteparin for the prevention of venous thromboembolism in acutely ill medical patients A Leizorovicz, AT Cohen, AGG Turpie, CG Olsson, PT Vaitkus, ... Circulation 110 (7), 874-879, 2004 | 1192 | 2004 |
| Efficacy and safety of fondaparinux for the prevention of venous thromboembolism in older acute medical patients: randomised placebo controlled trial AT Cohen, BL Davidson, AS Gallus, MR Lassen, MH Prins, W Tomkowski, ... Bmj 332 (7537), 325-329, 2006 | 1027 | 2006 |
| Andexanet alfa for acute major bleeding associated with factor Xa inhibitors SJ Connolly, TJ Milling Jr, JW Eikelboom, CM Gibson, JT Curnutte, A Gold, ... New England Journal of Medicine 375 (12), 1131-1141, 2016 | 881 | 2016 |
| Full study report of andexanet alfa for bleeding associated with factor Xa inhibitors SJ Connolly, M Crowther, JW Eikelboom, CM Gibson, JT Curnutte, ... New England Journal of Medicine 380 (14), 1326-1335, 2019 | 745 | 2019 |
| Rivaroxaban or aspirin for extended treatment of venous thromboembolism JI Weitz, AWA Lensing, MH Prins, R Bauersachs, J Beyer-Westendorf, ... New England Journal of Medicine 376 (13), 1211-1222, 2017 | 737 | 2017 |
| Apixaban for the treatment of venous thromboembolism associated with cancer G Agnelli, C Becattini, G Meyer, A Muñoz, MV Huisman, JM Connors, ... New England Journal of Medicine 382 (17), 1599-1607, 2020 | 732 | 2020 |
| Rivaroxaban for thromboprophylaxis in acutely ill medical patients AT Cohen, TE Spiro, HR Büller, L Haskell, D Hu, R Hull, A Mebazaa, ... New England Journal of Medicine 368 (6), 513-523, 2013 | 713 | 2013 |
| Risk factors for venous thromboembolism in hospitalized patients with acute medical illness: analysis of the MEDENOX Study R Alikhan, AT Cohen, S Combe, MM Samama, L Desjardins, A Eldor, ... Archives of internal medicine 164 (9), 963-968, 2004 | 696 | 2004 |
| Oral rivaroxaban versus standard therapy for the treatment of symptomatic venous thromboembolism: a pooled analysis of the EINSTEIN-DVT and PE randomized studies MH Prins, AWA Lensing, R Bauersachs, B Van Bellen, H Bounameaux, ... Thrombosis journal 11 (1), 1-10, 2013 | 636 | 2013 |
| ISIS-3: a randomised comparison of streptokinase vs tissue plasminogen activator vs antistreplase and of aspirin plus heparin vs aspirin along among 41 299 cases of suspected … D Hunt, J Varigos, F Dienstl, P Lechleitner, G De Backer, M Kornitzer, ... Lancet 339 (8796), 753-770, 1992 | 609 | 1992 |
| Low molecular weight versus standard heparin for prevention of venous thromboembolism after major abdominal surgery VV Kakkar, AT Cohen, RA Edmonson, MJ Phillips, SK Das, KT Maher, ... The Lancet 341 (8840), 259-265, 1993 | 510 | 1993 |
| Estimated annual number of incident and recurrent, non-fatal and fatal venous thromboembolism (VTE) events in the US. JA Heit, AT Cohen, FA Anderson Jr Blood 106 (11), 910, 2005 | 488* | 2005 |
| Extended thromboprophylaxis with betrixaban in acutely ill medical patients AT Cohen, RA Harrington, SZ Goldhaber, RD Hull, BL Wiens, A Gold, ... New England Journal of Medicine 375 (6), 534-544, 2016 | 487 | 2016 |
